Arkolith/Insider Trading/GLYC/Form 4

Rock Edwin

Chief Medical OfficerGLYCOMIMETICS INC (GLYC) · full profile →Form 4 · filed Jun 24, 2024
Net Buying
Open-Market Buys
$79K
Open-Market Sells
$0
Net Open-Market Flow
$79K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2024Buy(P)115K$0.27$31K680K
Jun 20, 2024Buy(P)190K$0.25$48K565K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-017978) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML